NCT04838171招募中不适用
Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies
Quell Therapeutics Limited1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2021年3月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- WBC characterisation to support the development of engineered regulatory T cells.
研究概览
简要总结
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •No additional inclusion/
排除标准
- •will be applied by Quell other than those specified by the consenting institutions.
结局指标
主要结局
WBC characterisation to support the development of engineered regulatory T cells.
时间窗: 5 years
number, type and function of white blood cells in healthy controls and in patients
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Allogeneic Transplantation in Patients With Cutaneous T-Cell LymphomaDisorder Related to Bone Marrow TransplantationLymphomaNCT00506129M.D. Anderson Cancer Center33
已完成
1 期
Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell TransplantsCytomegalovirus InfectionsNCT00674648Memorial Sloan Kettering Cancer Center30
终止
不适用
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated DonorsHealthyNCT03114566Memorial Sloan Kettering Cancer Center1
进行中（未招募）
1 期
A Blood Stem Cell Transplant for Sickle Cell DiseaseSickle Cell DiseaseSickle Cell DisorderHemoglobinopathiesAnemia, Sickle CellThalassemiaNCT03249831City of Hope Medical Center3
已完成
不适用
Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay DevelopmentHealthy SubjectsNCT00401232Pfizer955